aap Implantate AG Logo

aap Implantate AG

Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.

AAQ1 | F

Overview

Corporate Details

ISIN(s):
DE000A32VP65 (+4 more)
LEI:
39120001TRQTQ01LPP57
Country:
Germany
Address:
Lorenzweg 5, 12099 Berlin
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

aap Implantate AG is a medical technology company operating as a pure player in the trauma segment. It develops, manufactures, and markets orthopedic implants for trauma surgery worldwide. The company's core offering is the IP-protected LOQTEQ® anatomical plating system, a comprehensive portfolio of plates and screws based on a patented locking compression technology for fracture treatment. In addition to its established product line, aap focuses on developing next-generation platform technologies. Key innovations in development include silver-coated antibacterial implants to reduce infection risk and resorbable magnesium implants designed to biodegrade after fracture healing, thereby eliminating the need for removal surgeries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 22:00
Board/Management Information
aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka M…
English 10.6 KB
2025-09-16 10:00
Earnings Release
aap Implantate AG closes the first half of the year with sales of 6.2 million;…
English 27.1 KB
2025-09-12 12:00
Report Publication Announcement
English 3.7 KB
2025-09-09 15:00
Regulatory News Service
aap successfully completes human clinical trial for antibacterial surface techn…
English 12.8 KB
2025-09-02 09:54
Director's Dealing
aap Implantate AG: Nino Buckow, sell
German 6.4 KB
2025-08-15 15:00
Pre-Annual General Meeting Information
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.09…
German 41.1 KB
2025-08-06 09:24
Director's Dealing
aap Implantate AG: Nino Buckow, sell
German 6.5 KB
2025-08-05 12:13
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.4 KB
2025-08-01 12:15
Share Issue/Capital Change
aap Implantate AG: Full admission of all previously unadmitted shares, introduc…
English 8.7 KB
2025-07-21 20:55
Earnings Release
aap Implantate AG publishes final audited consolidated financial statements 202…
English 13.4 KB
2025-06-30 22:00
Annual Report
aap Implantate AG closes financial year 2024 successfully - positive developmen…
English 22.5 KB
2025-06-27 16:56
Report Publication Announcement
English 4.1 KB
2025-06-26 12:55
Report Publication Announcement
English 4.1 KB
2025-06-26 00:00
Report Publication Announcement
Berichtigung der Veröffentlichung vom 19.06.2025
German 5.7 KB
2025-06-26 00:00
Report Publication Announcement
Berichtigung der Veröffentlichung vom 19.06.2025
German 5.7 KB

Automate Your Workflow. Get a real-time feed of all aap Implantate AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for aap Implantate AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-06-15 di Girolamo, Rubino Board Buy None 990.00 EUR
2023-03-30 Deepblue Holding AG Close relation Other None 249,999.40 EUR
2023-03-30 Merval AG Close relation Other None 140,000.00 EUR
2023-03-30 di Girolamo, Rubino Board Other None 83,743.80 EUR
2023-03-30 Hahn, Marek Board Other None 52,920.00 EUR
2023-03-30 Mierzejewska, Agnieszka Board Other None 26,800.20 EUR
2022-02-03 Merval AG Close relation Other None 650,000.47 EUR
2021-10-28 Active Ownership Fund SICAV-FIS SCS Close relation Other None 60,792,157.00 EUR
2021-10-27 Merval AG Close relation Other None 318,324.60 EUR
2021-10-27 Visser, Biense Supervisory board Other None 3,573.90 EUR

Peer Companies

Company Country Ticker View
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
T&R Biofab Co., Ltd Logo
Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.
South Korea 246710
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.